BioCentury
ARTICLE | Company News

NaPro, F. H. Faulding & Co. Ltd. sales and marketing update

March 12, 2001 8:00 AM UTC

The companies expanded to Europe their 1995 marketing deal under which Faulding received rights to market NPRO's Anzatax paclitaxel in Australia, Asia, the Middle East, Latin America and South Africa ...